Business Description
Magle Chemoswed Holding AB
ISIN : SE0014401014
Share Class Description:
STU:52X: Ordinary SharesCompare
Compare
Traded in other countries / regions
MAGLE.Sweden52X.Germany IPO Date
2020-07-07Description
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.43 | |||||
| Debt-to-EBITDA | 4.29 | |||||
| Interest Coverage | 2.33 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.41 | |||||
| Beneish M-Score | -1.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.5 | |||||
| 3-Year EBITDA Growth Rate | 14.1 | |||||
| 3-Year EPS without NRI Growth Rate | 61.9 | |||||
| 3-Year Book Growth Rate | 8.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.91 | |||||
| 9-Day RSI | 54.97 | |||||
| 14-Day RSI | 51.89 | |||||
| 6-1 Month Momentum % | -30.89 | |||||
| 12-1 Month Momentum % | 24.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.97 | |||||
| Quick Ratio | 0.49 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 783.89 | |||||
| Days Sales Outstanding | 38.88 | |||||
| Days Payable | 364.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.6 | |||||
| Shareholder Yield % | -7.36 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 88.98 | |||||
| Operating Margin % | 7.22 | |||||
| Net Margin % | 8.12 | |||||
| FCF Margin % | 6.33 | |||||
| ROE % | 7.47 | |||||
| ROA % | 4.19 | |||||
| ROIC % | 3.6 | |||||
| ROC (Joel Greenblatt) % | 12.31 | |||||
| ROCE % | 8.57 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.01 | |||||
| PE Ratio without NRI | 64.39 | |||||
| PEG Ratio | 1.94 | |||||
| PS Ratio | 1.78 | |||||
| PB Ratio | 0.76 | |||||
| Price-to-Tangible-Book | 1.01 | |||||
| Price-to-Free-Cash-Flow | 28.1 | |||||
| Price-to-Operating-Cash-Flow | 28.1 | |||||
| EV-to-EBIT | 33.37 | |||||
| EV-to-EBITDA | 17.55 | |||||
| EV-to-Revenue | 4.13 | |||||
| EV-to-FCF | 66.51 | |||||
| Price-to-Graham-Number | 1.73 | |||||
| Earnings Yield (Greenblatt) % | 3 | |||||
| FCF Yield % | 2.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Magle Chemoswed Holding AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 18.272 | ||
| EPS (TTM) (€) | 0.137 | ||
| Beta | 1.19 | ||
| Volatility % | 45.21 | ||
| 14-Day RSI | 51.89 | ||
| 14-Day ATR (€) | 0.063915 | ||
| 20-Day SMA (€) | 2.757 | ||
| 12-1 Month Momentum % | 24.53 | ||
| 52-Week Range (€) | 2.078007 - 3.936225 | ||
| Shares Outstanding (Mil) | 19.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Magle Chemoswed Holding AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Magle Chemoswed Holding AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Magle Chemoswed Holding AB Frequently Asked Questions
What is Magle Chemoswed Holding AB(STU:52X)'s stock price today?
The current price of STU:52X is €2.82. The 52 week high of STU:52X is €3.94 and 52 week low is €2.08.
When is next earnings date of Magle Chemoswed Holding AB(STU:52X)?
The next earnings date of Magle Chemoswed Holding AB(STU:52X) is 2025-02-26.
Does Magle Chemoswed Holding AB(STU:52X) pay dividends? If so, how much?
Magle Chemoswed Holding AB(STU:52X) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers